تقرير
أعرض في EDS

Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival.

التفاصيل البيبلوغرافية
العنوان: Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival.
المؤلفون: Kumar NB, Dhurandhar M, Aggarwal B, Anant S, Daniel K, Deng G, Djeu J, Dou J, Hawk E, Jayaram B, Jia L, Joshi R, Kararala M, Karunagaran D, Kucuk O, Kumar L, Malafa M, Samathanam GJ, Sarkar F, Siddiqi M, Singh RP, Srivastava A, White JD
المصدر: Cancer medicine [Cancer Med] 2013 Feb; Vol. 2 (1), pp. 108-15.
نوع المنشور: Congress; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Malden, MA] : John Wiley & Sons Ltd., c2012-
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Biological Products/*therapeutic use , Drug Discovery/*methods , Neoplasms/*therapy, Biomedical Research/methods ; Chemoprevention/methods ; Drug Discovery/trends ; Humans ; International Cooperation
مستخلص: With the evolving evidence of the promise of botanicals/biologics for cancer chemoprevention and treatment, an Indo-U.S. collaborative Workshop focusing on “Accelerating Botanicals Agent Development Research for Cancer Chemoprevention and Treatment” was conducted at the Moffitt Cancer Center, 29–31 May 2012. Funded by the Indo-U.S. Science and Technology Forum, a joint initiative of Governments of India and the United States of America and the Moffitt Cancer Center, the overall goals of this workshop were to enhance the knowledge (agents, molecular targets, biomarkers, approaches, target populations, regulatory standards, priorities, resources) of a multinational, multidisciplinary team of researcher's to systematically accelerate the design, to conduct a successful clinical trials to evaluate botanicals/biologics for cancer chemoprevention and treatment, and to achieve efficient translation of these discoveries into the standards for clinical practice that will ultimately impact cancer morbidity and mortality. Expert panelists were drawn from a diverse group of stakeholders, representing the leadership from the National Cancer Institute's Office of Cancer Complementary and Alternative Medicine (OCCAM), NCI Experimental Therapeutics (NExT), Food and Drug Administration, national scientific leadership from India, and a distinguished group of population, basic and clinical scientists from the two countries, including leaders in bioinformatics, social sciences, and biostatisticians. At the end of the workshop, we established four Indo-U.S. working research collaborative teams focused on identifying and prioritizing agents targeting four cancers that are of priority to both countries. Presented are some of the key proceedings and future goals discussed in the proceedings of this workshop.
References: Cancer Res. 2005 Feb 1;65(3):1035-44. (PMID: 15705905)
JAMA. 2006 Jun 21;295(23):2727-41. (PMID: 16754727)
Mini Rev Med Chem. 2010 May;10(5):359-71. (PMID: 20370703)
Pharmacol Res. 2010 Oct;62(4):328-36. (PMID: 20542118)
Nutr Cancer. 2010;62(7):996-1000. (PMID: 20924975)
N Engl J Med. 2003 Mar 6;348(10):883-90. (PMID: 12621132)
Clin Colorectal Cancer. 2011 Jun;10(2):85-96. (PMID: 21859559)
J Chem Inf Model. 2006 Jan-Feb;46(1):78-85. (PMID: 16426042)
Sci Transl Med. 2010 Aug 18;2(45):45ra59. (PMID: 20720216)
Biochim Biophys Acta. 2004 Jun 1;1682(1-3):1-10. (PMID: 15158750)
Biochem Pharmacol. 2003 Sep 15;66(6):965-76. (PMID: 12963483)
N Engl J Med. 2003 Mar 6;348(10):891-9. (PMID: 12621133)
Nat Prod Rep. 2011 Nov;28(12):1937-55. (PMID: 21979811)
Drug Saf. 2002;25(14):1005-19. (PMID: 12408732)
Nutr Cancer. 2012;64(2):173-97. (PMID: 22149093)
Breast Cancer Res Treat. 2010 Aug;122(3):777-85. (PMID: 19898931)
Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G303-10. (PMID: 20522640)
Hum Exp Toxicol. 2010 Jun;29(6):513-24. (PMID: 20056736)
Nutr Cancer. 2007;59(1):1-7. (PMID: 17927495)
Nucleic Acids Res. 2006;34(21):6195-204. (PMID: 17090600)
J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88. (PMID: 9747868)
J Clin Trials. 2012 Jan 21;2(1):. (PMID: 24533253)
Int Immunopharmacol. 2011 Jul;11(7):890-8. (PMID: 21244860)
Mol Cancer Ther. 2011 Dec;10(12):2363-72. (PMID: 21971120)
Chin J Integr Med. 2012 May;18(5):325-32. (PMID: 22241505)
Am J Transl Res. 2012;4(1):14-23. (PMID: 22347519)
Cancer Prev Res (Phila). 2008 Jun;1(1):32-8. (PMID: 18841250)
Indian J Exp Biol. 2011 Nov;49(11):848-56. (PMID: 22126016)
N Engl J Med. 2006 Aug 31;355(9):873-84. (PMID: 16943400)
Nutr Cancer. 2007;59(2):169-75. (PMID: 18001211)
J Soc Integr Oncol. 2010 Winter;8(1):3-13. (PMID: 20205984)
J Clin Oncol. 2008 Jun 10;26(17):2813-20. (PMID: 18539959)
J Biomol Struct Dyn. 2010 Oct;28(2):133-42. (PMID: 20645648)
J Ethnopharmacol. 2011 Jun 14;136(1):83-7. (PMID: 21527335)
Clin Med Urol. 2008 Apr 16;1:1-14. (PMID: 20354574)
N Engl J Med. 1994 Apr 14;330(15):1029-35. (PMID: 8127329)
J Cancer Sci Ther. 2012;2011(S3):. (PMID: 22422102)
Eur J Pharmacol. 2012 Apr 15;681(1-3):6-14. (PMID: 22327045)
J Med Chem. 2007 May 3;50(9):2240-4. (PMID: 17419602)
Free Radic Res. 2010 Jun;44(6):624-34. (PMID: 20429769)
N Engl J Med. 2000 Jun 29;342(26):1946-52. (PMID: 10874062)
Eur J Pharmacol. 2010 Dec 15;649(1-3):84-91. (PMID: 20858478)
J Cancer Res Clin Oncol. 2009 Sep;135(9):1215-21. (PMID: 19253021)
Invest New Drugs. 2011 Aug;29(4):694-9. (PMID: 20107864)
Nutr Cancer. 2007;59(2):163-8. (PMID: 18001210)
J Natl Cancer Inst. 1996 Nov 6;88(21):1550-9. (PMID: 8901853)
Eur J Cancer Prev. 2012 Sep;21(5):407-12. (PMID: 22156994)
معلومات مُعتمدة: R01 CA122060 United States CA NCI NIH HHS
المشرفين على المادة: 0 (Antineoplastic Agents)
0 (Biological Products)
تواريخ الأحداث: Date Created: 20131128 Date Completed: 20140519 Latest Revision: 20211021
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC3797562
DOI: 10.1002/cam4.42
PMID: 24279005
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-7634
DOI:10.1002/cam4.42